{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Valsartan+80+mg", "query": { "intervention": "Valsartan 80 mg" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 33, "total_pages": 4, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Valsartan+80+mg&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-27T14:18:38.070Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00433836", "title": "Effect of Valsartan Compared to Enalapril on Sitting Systolic Blood Pressure in Children With High Blood Pressure", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Hypertension" ], "interventions": [ { "name": "Valsartan", "type": "DRUG" }, { "name": "Enalapril", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "6 Years to 17 Years" }, "enrollment_count": 300, "start_date": "2007-01", "completion_date": "2009-02", "has_results": true, "last_update_posted_date": "2011-05-19", "last_synced_at": "2026-09-27T14:18:38.070Z", "location_count": 1, "location_summary": "East Hanover, New Jersey", "locations": [ { "city": "East Hanover", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT00433836" }, { "nct_id": "NCT00446511", "title": "Extension Study to Assess Long Term Safety, Tolerability, and Efficacy of Valsartan and Enalapril Combined and Alone in Children With Hypertension", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Hypertension" ], "interventions": [ { "name": "Valsartan", "type": "DRUG" }, { "name": "Enalapril", "type": "DRUG" }, { "name": "placebo matched to enalapril", "type": "DRUG" }, { "name": "placebo matched to valsartan", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "6 Years to 17 Years" }, "enrollment_count": 250, "start_date": "2007-06", "completion_date": "2009-06", "has_results": true, "last_update_posted_date": "2011-07-12", "last_synced_at": "2026-09-27T14:18:38.070Z", "location_count": 1, "location_summary": "East Hanover, New Jersey", "locations": [ { "city": "East Hanover", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT00446511" }, { "nct_id": "NCT02884206", "title": "Efficacy and Safety of LCZ696 Compared to Valsartan on Cognitive Function in Patients With Chronic Heart Failure and Preserved Ejection Fraction", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Chronic Heart Failure (CHF)" ], "interventions": [ { "name": "LCZ696", "type": "DRUG" }, { "name": "Valsartan", "type": "DRUG" }, { "name": "Placebo of LCZ696", "type": "DRUG" }, { "name": "Placebo of Valsartan", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "60 Years", "maximum_age": null, "sex": "ALL", "summary": "60 Years and older" }, "enrollment_count": 592, "start_date": "2016-11-23", "completion_date": "2022-05-16", "has_results": true, "last_update_posted_date": "2024-08-06", "last_synced_at": "2026-09-27T14:18:38.070Z", "location_count": 52, "location_summary": "Andalusia, Alabama • Glendale, Arizona • Mesa, Arizona + 45 more", "locations": [ { "city": "Andalusia", "state": "Alabama" }, { "city": "Glendale", "state": "Arizona" }, { "city": "Mesa", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Sun City West", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT02884206" }, { "nct_id": "NCT00409578", "title": "Efficacy and Safety of Aliskiren and Valsartan Versus Placebo in Patients Stabilized Following an Acute Coronary Syndrome", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Post Acute Coronary Syndrome", "Myocardial Ischemia" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "Aliskiren 300 mg", "type": "DRUG" }, { "name": "Valsartan 320 mg", "type": "DRUG" }, { "name": "Aliskiren/valsartan 300/320 mg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1101, "start_date": "2007-02", "completion_date": "2009-04", "has_results": true, "last_update_posted_date": "2011-04-19", "last_synced_at": "2026-09-27T14:18:38.070Z", "location_count": 1, "location_summary": "Investigative Site, New Jersey", "locations": [ { "city": "Investigative Site", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT00409578" }, { "nct_id": "NCT04971720", "title": "PRECISION-BP: Precision Chronopharamacotherapy Targeting NP-RAAS-BP Rhythm Axis", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Obesity", "Cardiovascular Diseases", "Hypertension", "Nocturnal Blood Pressure", "Natriuretic Peptides", "Renin-Angiotensin-Aldosterone System" ], "interventions": [ { "name": "Sacubitril-Valsartan 49 Mg-51 Mg Oral Tablet", "type": "DRUG" }, { "name": "Valsartan 80 mg Oral Tablet", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Alabama at Birmingham", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 160, "start_date": "2022-02-18", "completion_date": "2027-01-01", "has_results": false, "last_update_posted_date": "2026-04-09", "last_synced_at": "2026-09-27T14:18:38.070Z", "location_count": 1, "location_summary": "Birmingham, Alabama", "locations": [ { "city": "Birmingham", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT04971720" }, { "nct_id": "NCT00034840", "title": "Telmisartan vs. Valsartan in Patients With Mild to Moderate Hypertension Following a Missed Dose", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Hypertension" ], "interventions": [ { "name": "telmisartan, valsartan", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 490, "start_date": "2001-10", "completion_date": "2002-08", "has_results": false, "last_update_posted_date": "2013-11-01", "last_synced_at": "2026-09-27T14:18:38.070Z", "location_count": 16, "location_summary": "Long Beach, California • Los Angeles, California • Orange, California + 12 more", "locations": [ { "city": "Long Beach", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Orange", "state": "California" }, { "city": "Farmington", "state": "Connecticut" }, { "city": "Fort Lauderdale", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT00034840" }, { "nct_id": "NCT03988634", "title": "Changes in NT-proBNP, Safety, and Tolerability in HFpEF Patients With a WHF Event (HFpEF Decompensation) Who Have Been Stabilized and Initiated at the Time of or Within 30 Days Post-decompensation (PARAGLIDE-HF)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Heart Failure With Preserved Ejection Fraction (HFpEF)" ], "interventions": [ { "name": "sacubitril/valsartan", "type": "DRUG" }, { "name": "valsartan", "type": "DRUG" }, { "name": "sacubitril/valsartan matching placebo", "type": "DRUG" }, { "name": "valsartan matching placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "99 Years", "sex": "ALL", "summary": "18 Years to 99 Years" }, "enrollment_count": 467, "start_date": "2019-06-29", "completion_date": "2022-12-14", "has_results": true, "last_update_posted_date": "2025-03-06", "last_synced_at": "2026-09-27T14:18:38.070Z", "location_count": 87, "location_summary": "Irvine, California • Long Beach, California • Los Angeles, California + 77 more", "locations": [ { "city": "Irvine", "state": "California" }, { "city": "Long Beach", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03988634" }, { "nct_id": "NCT01508026", "title": "Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Stage 1 Hypertension", "Stage 2 Hypertension" ], "interventions": [ { "name": "Nebivolol and Valsartan 1", "type": "DRUG" }, { "name": "Nebivolol and Valsartan 2", "type": "DRUG" }, { "name": "Nebivolol and Valsartan 3", "type": "DRUG" }, { "name": "Nebivolol 1", "type": "DRUG" }, { "name": "Nebivolol 2", "type": "DRUG" }, { "name": "Valsartan 1", "type": "DRUG" }, { "name": "Valsartan 2", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Forest Laboratories", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 4161, "start_date": "2012-01", "completion_date": "2013-05", "has_results": false, "last_update_posted_date": "2014-04-25", "last_synced_at": "2026-09-27T14:18:38.070Z", "location_count": 413, "location_summary": "Birmingham, Alabama • Foley, Alabama • Gulf Shores, Alabama + 290 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT01508026" }, { "nct_id": "NCT00591578", "title": "Efficacy and Safety Comparison of Azilsartan Medoxomil to Valsartan in Participants With Essential Hypertension", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Hypertension" ], "interventions": [ { "name": "Azilsartan Medoxomil", "type": "DRUG" }, { "name": "Valsartan", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Takeda", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 984, "start_date": "2007-12", "completion_date": "2010-03", "has_results": true, "last_update_posted_date": "2012-02-02", "last_synced_at": "2026-09-27T14:18:38.070Z", "location_count": 77, "location_summary": "Huntsville, Alabama • Glendale, Arizona • Phoenix, Arizona + 74 more", "locations": [ { "city": "Huntsville", "state": "Alabama" }, { "city": "Glendale", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Tuscon", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT00591578" }, { "nct_id": "NCT02606279", "title": "Angiotensin Receptors and Age Related Mitochondrial Decline in HIV Patients", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "HIV", "Aging", "Sarcopenia", "Angiotensin Receptor Antagonists" ], "interventions": [ { "name": "valsartan", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Wake Forest University Health Sciences", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": "60 Years", "sex": "ALL", "summary": "40 Years to 60 Years" }, "enrollment_count": 1, "start_date": "2014-07", "completion_date": "2016-08-04", "has_results": true, "last_update_posted_date": "2018-08-28", "last_synced_at": "2026-09-27T14:18:38.070Z", "location_count": 1, "location_summary": "Winston-Salem, North Carolina", "locations": [ { "city": "Winston-Salem", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT02606279" } ] }